GSK's linerixibat achieved significant itch reduction in a late-stage trial for cholestatic pruritus, meeting key goals. Read ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

While it may be helpful to take turmeric every day due to its anti-inflammatory benefits, it's possible to overdo it. Here's ...

Speaking in an emotional interview on Biola Bayo’s podcast, Harrison disclosed that he was forced to sell his house, cars, ...

About 200,000 people in Nigeria, mostly children, lose their lives annually from food-related diseases. In addition, Nigeria ...

European Region has the heaviest alcohol consumption of all regions in the world, causing a significant reduction in life expectancy, especially among men. Approximately 800,000 lives are lost each ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent condition that affects around 2 million people in the UK.

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...

Liver disease patients are falling through the cracks and not getting the treatment they need. Support from people with lived experience of disease could bridge the gap.

High-fructose corn syrup, prevalent in many processed foods, is a simple carbohydrate that offers minimal nutritional value and contributes to obesity ...

By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

A recent study found that six cardiometabolic risk groups previously identified in middle-aged individuals can also be applied to older adults without diabetes. Using data from the KORA F4/FF4 study ...